Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
about
Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell LinesArctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation
P2860
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@en
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@nl
type
label
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@en
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@nl
prefLabel
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@en
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@nl
P2093
P2860
P1476
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.
@en
P2093
Khadijeh Jamialahmadi
Maryam Matbou Riahi
Parvin Zamani
P2860
P304
P356
10.1080/21691401.2017.1388250
P577
2017-10-12T00:00:00Z